Compounds > amikacin
Page last updated: 2024-08-23

amikacin and beta-lactams

amikacin has been researched along with beta-lactams in 58 studies

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-19908 (13.79)18.7374
1990's9 (15.52)18.2507
2000's9 (15.52)29.6817
2010's31 (53.45)24.3611
2020's1 (1.72)2.80

Authors

AuthorsStudies
Aujard, Y; Bennani, H; Bingen, E; Darbord, JC; Goury, V; Lambert-Zechovsky, N1
Hanberger, H; Isaksson, B; Maller, R; Nilsson, LE; Nilsson, M1
Feldman, S; Ravis, WR; Van, R; Walterspiel, JN1
Alvarez, S; Berk, SL; Holtsclaw-Berk, S; Jones, M1
Aulicino, TM; Gombert, ME1
McNamara, BT; Meyer, RD; Pasiecznik, KA1
Glew, RH; Pavuk, RA2
Bruckner, DA; Kurtz, TO; Martin, WJ; Winston, DJ1
Marks, MI; Scribner, RK; Tarpay, MM; Weber, AH; Welch, DF1
Gombert, ME1
Kahr, A; Michéa-Hamzehpour, M; Pechère, JC1
Godard, C; Hannecart-Pokorni, E; Hubrechts, JM; Maes, P; Nulens, E; Nyssen, HJ; Vanhoof, R; Wildemauwe, C1
Carbon, C; Farinotti, R; Goldstein, F; Gutmann, L; Mainardi, JL; Mohler, J; Zhou, XY1
Berrouane, Y; Courcol, RJ; Goffart, M; Gourde, B; Roussel-Delvallez, M; Sirot, D; Wallet, F1
Cavallo, JD; Dubrous, P; Fabre, R; Hernandez, E; Nordmann, P1
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R1
Andre, C; Arpin, C; Dubois, V; Frigo, C; Melon, B; Melon, M; Quentin, C1
Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H1
De Vecchi, E; Drago, L; Gismondo, MR; Legnani, D; Lombardi, A; Nicola, L1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L; Tocalli, L1
Leaños-Miranda, BE; Miranda-Novales, G; Solórzano-Santos, F; Vilchis-Pérez, M1
Bhat, S; Capitano, B; Fujitani, S; Linden, PK; Paterson, DL; Potoski, BA; Shutt, K1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L1
Ba, T; Gao, BQ; Li, YY; Ma, WH; Meng, ZY; Wang, LF; Wang, XD; Yu, QP; Zhang, J; Zhang, LH1
Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN1
Conejo, Mdel C; Hernández, JR; Pascual, A1
Cumps, J; Delattre, IK; Dugernier, T; Jacobs, F; Laterre, PF; Musuamba, FT; Spapen, H; Taccone, FS; Verbeeck, RK; Vincent, JL; Wallemacq, PE; Wittebole, X1
Badal, RE; Bouchillon, SK; DiPersio, J; Hawser, SP; Hoban, DJ; Labombardi, VJ1
Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F1
Balada-Llasat, JM; Buckosh, M; Hemminger, J; Pancholi, P; Raczkowski, M1
Badal, RE; Bouchillon, SK; Cantón, R; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C1
Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C; Livermore, DM; Woodford, N1
Delattre, IK; Jacobs, F; Jacqmin, P; Laterre, PF; Musuamba, FT; Taccone, FS; Verbeeck, RK; Wallemacq, P1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW1
Burian, A; Erdogan, Z; Jandrisits, C; Zeitlinger, M1
Colares, AV; Costa, JG; Coutinho, HD; Ferreira, EO; Figueiredo, PR; Figueredo, FG; Kerntopf, MR; Lucena, BF; Lucetti, DL; Lucetti, EC; Matias, EF; Medeiros, CR; Menezes, IR; Oliveira, GM; Santos, FA; Silva, JC; Silva, JM; Torres, CM1
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ1
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C1
Almaghrabi, R; Chen, L; Clancy, CJ; Doi, Y; Hao, B; Iovine, NM; Kreiswirth, B; Nguyen, MH; Press, EG; Shields, RK; Townsend, BM; Wagener, MM1
Bajaj, H; Benz, R; Mahendran, KR; Singh, PR; Winterhalter, M1
Albano, RM; Asensi, MD; Borghi, M; Carvalho-Assef, AP; Lopes, JC; Marques, EA; Oliveira, JC; Pereira, PS; Silveira, MC1
Bursle, E; Cotta, MO; Gowen, B; Lipman, J; McWhinney, B; Roberts, JA; Truloff, N; Ungerer, JP1
Graves, B; Hajkowicz, K; Paterson, DL; Stewart, A; Ta, K1
Gentry, CA; Williams, RJ1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH1
de Jonge, BL; Karlowsky, JA; Kazmierczak, KM; Nichols, WW; Sahm, DF1
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ1
Nicolau, DP; Sutherland, CA; Verastegui, JE1
Dinic, M; Kocic, B; Mitic, R; Mladenovic-Antic, S; Petrovic, J; Randjelovic, G; Velickovic-Radovanovic, R1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N1
Abdel-Haq, N; Ang, JY; Nicolau, DP; Satlin, MJ; Thabit, AK; van Duin, D; Zhu, F1
Barkham, TM; Chen, H; Gin, KY; Koh, TH; Le, TH; Ng, C; Yi, XZ; Zhou, Z1
Hackel, MA; Hoban, DJ; Karlowsky, JA; Lob, SH; Sahm, DF1
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P1
Batzias, GC; Delis, GA; Koutsoviti-Papadopoulou, M; Siarkou, VI; Vingopoulou, EI1
Fukui, M; Marumo, S; Shirata, M; Tamai, K; Yoshimoto, Y1

Trials

1 trial(s) available for amikacin and beta-lactams

ArticleYear
Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
    Clinical biochemistry, 2012, Volume: 45, Issue:10-11

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Critical Illness; Drug Monitoring; Female; Humans; Male; Meropenem; Metabolic Clearance Rate; Middle Aged; Models, Biological; Piperacillin; Sepsis; Thienamycins; Tissue Distribution; Treatment Outcome

2012

Other Studies

57 other study(ies) available for amikacin and beta-lactams

ArticleYear
Bactericidal activity of beta-lactams and amikacin against Haemophilus influenzae: effect on endotoxin release.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactams; Endotoxins; Haemophilus influenzae; Humans; In Vitro Techniques; Infant; Kinetics; Limulus Test; Macrophages; Mice; Microbial Sensitivity Tests; Tumor Necrosis Factor-alpha

1992
Synergic post-antibiotic effect of amikacin in combination with beta-lactam antibiotics on gram-negative bacteria.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 28, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Drug Therapy, Combination; Luminescent Measurements; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serratia marcescens

1991
Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:9

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cilastatin; Drug Interactions; Fluorescence Polarization Immunoassay; Gentamicins; Heparin; Humans

1991
In vitro interactions of amikacin and beta-lactam antibiotics against amikacin-resistant gram-negative bacilli.
    Chemotherapy, 1988, Volume: 34, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria

1988
Amikacin synergism with beta-lactam antibiotics against selected nosocomial pathogens.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Humans; Kanamycin; Microbial Sensitivity Tests

1986
In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalothin; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa

1982
Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Kanamycin; Microbial Sensitivity Tests

1984
Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics.
    Antimicrobial agents and chemotherapy, 1983, Volume: 24, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Chemistry, Pharmaceutical; Drug Combinations; Drug Stability; Gentamicins; Temperature; Tobramycin

1983
Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serratia marcescens

1981
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:6

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cystic Fibrosis; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin

1982
Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Combinations; Imipenem; Microbial Sensitivity Tests; Nocardia asteroides; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1982
In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.
    Infection, 1994, Volume: 22 Suppl 2

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Evaluation Studies as Topic; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infection Control; Risk Factors

1994
Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.
    The Journal of hospital infection, 1993, Volume: 24, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Belgium; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals; Humans; Pseudomonas aeruginosa; Serotyping

1993
Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l
    The Journal of infectious diseases, 1994, Volume: 169, Issue:6

    Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Female; Gentamicins; Klebsiella pneumoniae; Mutation; Rabbits

1994
Bactericidal effect of beta-lactams and amikacin alone or in association against Klebsiella pneumoniae producing extended spectrum beta-lactamase.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Therapy, Combination; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests

1995
[Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].
    Pathologie-biologie, 1997, Volume: 45, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Drug Therapy, Combination; In Vitro Techniques; Phenotype; Pseudomonas aeruginosa

1997
Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.
    Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic

1997
Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:6

    Topics: Adult; Amikacin; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Ribotyping

2001
Efficacy of amikacin combinations for nocardiosis.
    The Tohoku journal of experimental medicine, 2003, Volume: 201, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim

2003
In vitro synergy and selection of resistance by fluoroquinolones plus amikacin or beta-lactams against extended-spectrum beta-lactamase-producing Escherichia coli.
    Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:1

    Topics: Amikacin; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mutation

2005
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:2

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pseudomonas aeruginosa

2005
In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Annals of clinical microbiology and antimicrobials, 2006, Oct-12, Volume: 5

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cephalothin; Dicloxacillin; Drug Synergism; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin

2006
Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:5

    Topics: Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Intensive Care Units; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors

2007
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    BMC infectious diseases, 2007, Sep-21, Volume: 7

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

2007
[Optimization of antibiotics in combination].
    Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2008, Volume: 24, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Burn Units; Ciprofloxacin; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2008
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
    The West Indian medical journal, 2008, Volume: 57, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin

2008
[Comparative activity of ertapenem against extended-spectrum beta-lactamase-producing or plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; R Factors; Substrate Specificity

2010
Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.
    Clinical biochemistry, 2010, Volume: 43, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Calibration; Critical Illness; Drug Dosage Calculations; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Empirical Research; Female; Humans; Male; Middle Aged; Models, Theoretical; Sepsis; Young Adult

2010
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Abdomen; Amikacin; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests

2010
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins

2011
Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.
    Infection, 2011, Volume: 39, Issue:4

    Topics: Adult; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Clostridioides difficile; Clostridium Infections; Comorbidity; Humans; Male; Ohio; Treatment Outcome; Vancomycin

2011
Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009).
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Europe; Female; Humans; Imipenem; Intraabdominal Infections; Male; Microbial Sensitivity Tests

2012
Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2011
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
    International journal of antimicrobial agents, 2012, Volume: 40 Suppl

    Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections

2012
Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.
    Pharmacology, 2012, Volume: 90, Issue:5-6

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Colistin; Ertapenem; Fosfomycin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Trimethoprim; Urine

2012
Modulation of the antibiotic activity by extracts from Amburana cearensis A. C. Smith and Anadenanthera macrocarpa (Benth.) Brenan.
    BioMed research international, 2013, Volume: 2013

    Topics: Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Escherichia coli; Fabaceae; Microbial Sensitivity Tests; Mimosa; Plant Extracts; Plant Leaves; Staphylococcus aureus

2013
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
    Clinical therapeutics, 2013, Volume: 35, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Female; Gram-Negative Bacteria; Humans; Imipenem; Inpatients; Male; United States; Urinary Tract Infections

2013
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1

    Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index

2014
Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enzyme Assays; Gene Expression; Gentamicins; Isoenzymes; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin

2014
Transport across the outer membrane porin of mycolic acid containing actinomycetales: Nocardia farcinica.
    Biochimica et biophysica acta, 2015, Volume: 1848, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Biological Transport; Cell Membrane; Cell Wall; Ertapenem; Escherichia coli; Gene Expression; Hydrophobic and Hydrophilic Interactions; Kanamycin; Liposomes; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Mycolic Acids; Nocardia; Porins; Recombinant Proteins; Static Electricity; Structural Homology, Protein

2015
Coproduction of NDM-1 and KPC-2 in Enterobacter hormaechei from Brazil.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:2

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Brazil; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Polymyxin B

2015
Even high-dose extended infusions may not yield desired concentrations of β-lactams: the value of therapeutic drug monitoring.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:10

    Topics: Adult; Amikacin; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Bacterial; Female; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Thienamycins

2015
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Meropenem; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus epidermidis; Thienamycins

2015
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs

2015
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2016
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine

2016
In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014).
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8

    Topics: Africa; Amikacin; Anti-Bacterial Agents; Asia; Azabicyclo Compounds; beta-Lactams; Ceftazidime; Colistin; Drug Combinations; Humans; Latin America; Meropenem; Microbial Sensitivity Tests; Middle East; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin

2016
In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
    Annals of clinical microbiology and antimicrobials, 2016, Jun-17, Volume: 15, Issue:1

    Topics: Administration, Inhalation; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Pseudomonas aeruginosa; Pseudomonas Infections; United States

2016
Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
    Journal of clinical pharmacy and therapeutics, 2016, Volume: 41, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Gentamicins; Hospitals; Humans; Imipenem; Meropenem; Pseudomonas aeruginosa; Serbia; Thienamycins

2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Clinical therapeutics, 2016, Volume: 38, Issue:9

    Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam

2016
Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2016
Occurrences and Characterization of Antibiotic-Resistant Bacteria and Genetic Determinants of Hospital Wastewater in a Tropical Country.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12

    Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Chromatography, Liquid; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli Proteins; Hospitals; Humans; Integrases; Singapore; Tandem Mass Spectrometry; Trimethoprim, Sulfamethoxazole Drug Combination; Wastewater

2016
Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Journal of medical microbiology, 2017, Volume: 66, Issue:1

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Asia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Ertapenem; Gram-Negative Bacteria; Hospitalization; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Urinary Tract Infections

2017
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
    The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections

2017
Pharmacodynamic interactions of amikacin with selected β-lactams and fluoroquinolones against canine Escherichia coli isolates.
    Research in veterinary science, 2018, Volume: 117

    Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactams; Dog Diseases; Dogs; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests

2018
In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97

    Topics: Actinomycetales Infections; Amikacin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacteriaceae; Sequence Analysis, DNA

2020